Naohiro Makita

Title: Naohiro Makita: Innovating Drug Response Testing in Cardiac Research

Introduction

Naohiro Makita is a distinguished inventor based in Kyoto, Japan, known for his significant contributions to cardiac research. With a focus on enhancing drug response testing, he has proven to be a valuable asset in the field of biomedical innovation.

Latest Patents

Makita holds a patent for a groundbreaking method titled "Method for testing drug response of cardiomyocytes." This innovative technique involves testing the response of cardiomyocytes to added drugs while maintaining specific conditions in the culture medium. Specifically, the method ensures that the distance from the liquid surface of the culture medium to the bottom surface of the culture vessel, contacted by the cardiomyocyte, is 5.0 mm or less. This precision enhances the accuracy of drug response testing and has important implications for cardiac drug development.

Career Highlights

Currently, Naohiro Makita is associated with Myoridge Co. Ltd., where he continues to push the boundaries of research and innovation. His work has been vital in formulating new methods that tackle challenges in cardiomyocyte research, ultimately aiding in the advancement of therapeutic strategies for heart conditions.

Collaborations

Naohiro frequently collaborates with notable colleagues, including Shinichi Sueta and Itsunari Minami. Together, they contribute to ongoing research efforts that align with their collective goal of improving cardiac health through innovative technology and methodologies.

Conclusion

With a focus on interdisciplinary collaboration and a commitment to advancing cardiac research, Naohiro Makita exemplifies the spirit of innovation. His patented method not only showcases his inventiveness but also holds promise for future advancements in drug testing and treatment for cardiovascular diseases. As he continues his work at Myoridge Co. Ltd., Makita remains a key figure in the quest for better healthcare solutions.